Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 1345-1350, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (69)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wayand, D.
Right arrow Articles by Neumeier, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wayand, D.
Right arrow Articles by Neumeier, D.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2000;46:1345-1350.)
© 2000 American Association for Clinical Chemistry, Inc.


Articles

Cardiac Troponin T and I in End-Stage Renal Failure

Diana Wayand1, Hannsjörg Baum1,a, Gabriele Schätzle2, Julia Schärf2 and Dieter Neumeier1

1 Institut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, Ismaningerstrasse 22, D-81675 Munich, Germany.

2 Dialysezentrum Ost, D-81671 Munich, Germany.
a Author for correspondence. Fax 49-89-4140-4875; e-mail baum{at}klinchem.med.tu-muenchen.de

Background: In patients suffering from end-stage renal failure, cardiac troponin T (cTnT) and I (cTnI) may be increased in serum without other signs of acute myocardial damage. Whether these increases are specific to myocardial injury or nonspecific is not completely clear.

Methods: We investigated time courses of cTnT and cTnI over 1 year and the clinical outcome over 2 years in 59 patients with end-stage renal failure undergoing chronic hemodialysis. At the start of the study, we divided the patients into two groups, group 1, without history of cardiac failure, and group 2, with history of cardiac failure, and looked for differences between the groups in later adverse outcome. cTnT was measured using the Enzymun® troponin T assay on an ES 700 analyzer (Roche). cTnI was measured on a Stratus® II analyzer (Dade Behring). Creatinine and blood urea nitrogen were measured on a Vitros® 950 IRC (Ortho).

Results: Dialysis acutely increased cTnT (P <0.01) and decreased cTnI (P <0.001) regardless of the dialysis membrane used. Although statistically not significant, cTnT but not cTnI was increased more frequently in group 2 than in group 1, in some cases over the whole study period. Five patients (8.5%) died of cardiac complications within 2 years; all of them had mostly increased cTnT and, in one or more samples, increased cTnI.

Conclusions: Dialysis alters measured cTnT and cTnI concentrations in serum. In patients suffering from end-stage renal failure, sporadic or persistently increased cTnT and cTnI appear to predict cardiac complications. Because of the effects of the dialysis procedure on troponin values, we recommend that blood be collected before dialysis.




The following articles in journals at HighWire Press have cited this article:


Home page
Nephrol Dial TransplantHome page
J. J. Dasselaar, R. H. J. A. Slart, M. Knip, J. Pruim, R. A. Tio, C. W. McIntyre, P. E. de Jong, and C. F. M. Franssen
Haemodialysis is associated with a pronounced fall in myocardial perfusion
Nephrol. Dial. Transplant., September 4, 2008; (2008) gfn501v1.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Y.-M. Wang and K.-N. Lai
Use of Cardiac Biomarkers in End-Stage Renal Disease
J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1643 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, A. H.B. Wu, A. S. Jaffe, F. S. Apple, R. L. Jesse, G. L. Francis, D. A. Morrow, L. K. Newby, J. Ravkilde, W.H. W. Tang, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure
Clin. Chem., December 1, 2007; 53(12): 2086 - 2096.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
N. M. Selby, J. O. Burton, L. J. Chesterton, and C. W. McIntyre
Dialysis-Induced Regional Left Ventricular Dysfunction Is Ameliorated by Cooling the Dialysate
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1216 - 1225.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
B. Conway, M. McLaughlin, P. Sharpe, and J. Harty
Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis
Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2759 - 2764.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Lauer
Cardiac Troponins and Renal Failure: The Evolution of a Clinical Test
Circulation, November 15, 2005; 112(20): 3036 - 3037.
[Full Text] [PDF]


Home page
CirculationHome page
N. A. Khan, B. R. Hemmelgarn, M. Tonelli, C. R. Thompson, and A. Levin
Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis
Circulation, November 15, 2005; 112(20): 3088 - 3096.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. Babuin and A. S. Jaffe
Troponin: the biomarker of choice for the detection of cardiac injury
Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
H.H.H. Feringa, J.J. Bax, O. Schouten, and D. Poldermans
Ischemic heart disease in renal transplant candidates: Towards non-invasive approaches for preoperative risk stratification
Eur J Echocardiogr, October 1, 2005; 6(5): 313 - 316.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. T. Yan, R. T. Yan, M. Tan, C.-M. Chow, D. Fitchett, E. Stanton, A. Langer, S. G. Goodman, and for the Canadian Acute Coronary Syndromes Registr
Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients
Eur. Heart J., November 2, 2004; 25(22): 2006 - 2012.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. Ritter, P. A. Lee, J. F. Taylor, L. Hsu, J. D. Cohen, H. D. Chung, and K. S. Virgo
Troponin I in Patients without Chest Pain
Clin. Chem., January 1, 2004; 50(1): 112 - 119.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. deFilippi, S. Wasserman, S. Rosanio, E. Tiblier, H. Sperger, M. Tocchi, R. Christenson, B. Uretsky, M. Smiley, J. Gold, et al.
Cardiac Troponin T and C-Reactive Protein for Predicting Prognosis, Coronary Atherosclerosis, and Cardiomyopathy in Patients Undergoing Long-term Hemodialysis
JAMA, July 16, 2003; 290(3): 353 - 359.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
S. E. Lipshultz, M. J. G. Somers, S. R. Lipsitz, S. D. Colan, K. Jabs, and N. Rifai
Serum Cardiac Troponin and Subclinical Cardiac Status in Pediatric Chronic Renal Failure
Pediatrics, July 1, 2003; 112(1): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Beciani, A. Tedesco, A. Violante, S. Cipriani, M. Azzarito, A. Sturniolo, and G. Splendiani
Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value
Nephrol. Dial. Transplant., May 1, 2003; 18(5): 942 - 946.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Freda, W. H. W. Tang, F. Van Lente, W. F. Peacock, and G. S. Francis
Cardiac troponins in renal insufficiency: Review and clinical implications
J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2065 - 2071.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Lowbeer, A. Gutierrez, S. A. Gustafsson, R. Norrman, J. Hulting, and A. Seeberger
Elevated cardiac troponin T in peritoneal dialysis patients is associated with CRP and predicts all-cause mortality and cardiac death
Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2178 - 2183.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. J. Quinn and D. J. Moliterno
Troponins in Acute Coronary Syndromes: More TACTICS for an Early Invasive Strategy
JAMA, November 21, 2001; 286(19): 2461 - 2462.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Jaffe
Testing the wrong hypothesis: the failure to recognize the limitations of troponin assays
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 999 - 1001.
[Full Text] [PDF]


Home page
CirculationHome page
J. Feng, B. J. Schaus, J. A. Fallavollita, T.-C. Lee, and J. M. Canty Jr
Preload Induces Troponin I Degradation Independently of Myocardial Ischemia
Circulation, April 24, 2001; 103(16): 2035 - 2037.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. K. Davis, R. Labugger, J. E. Van Eyk, and F. S. Apple
Cardiac Troponin T Is Not Detected in Western Blots of Diseased Renal Tissue
Clin. Chem., April 1, 2001; 47(4): 782 - 783.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
D. S. Ooi, D. Zimmerman, J. Graham, and G. A. Wells
Cardiac Troponin T Predicts Long-Term Outcomes in Hemodialysis Patients
Clin. Chem., March 1, 2001; 47(3): 412 - 417.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Hammerer-Lercher, P. Erlacher, R. Bittner, R. Korinthenberg, D. Skladal, S. Sorichter, W. Sperl, B. Puschendorf, and J. Mair
Clinical and Experimental Results on Cardiac Troponin Expression in Duchenne Muscular Dystrophy
Clin. Chem., March 1, 2001; 47(3): 451 - 458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.